EXAGEN INC. - COMMON S
3.9700
29-November-24 13:45:00
15 minutes delayed
Stocks
+0.1300
+3.39%
Today's range
3.7201 - 4.0000
ISIN
N/A
Source
NASDAQ
-
Exagen Inc. Reports First Quarter 2021 Results
11 May 2021 16:05:01 By Nasdaq GlobeNewswire
-
04 May 2021 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Announces New Campaign and Initiatives for Lupus Awareness Month
03 May 2021 08:25:00 By Nasdaq GlobeNewswire
-
Exagen to Announce First Quarter 2021 Financial Results on May 11, 2021
27 Apr 2021 16:05:01 By Nasdaq GlobeNewswire
-
29 Mar 2021 08:25:00 By Nasdaq GlobeNewswire
-
25 Mar 2021 16:15:47 By Nasdaq GlobeNewswire
-
Exagen Inc. Announces Pricing of Public Offering of Common Stock
22 Mar 2021 22:01:09 By Nasdaq GlobeNewswire
-
Exagen Inc. Announces Proposed Public Offering of Common Stock
22 Mar 2021 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results
16 Mar 2021 16:05:00 By Nasdaq GlobeNewswire
-
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 16, 2021
02 Mar 2021 08:00:01 By Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in the Cowen 41st Annual Health Care Conference
22 Feb 2021 16:05:00 By Nasdaq GlobeNewswire
-
03 Feb 2021 16:05:00 By Nasdaq GlobeNewswire
-
21 Jan 2021 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results
10 Jan 2021 18:00:00 By Nasdaq GlobeNewswire
-
Exagen Inc. To Participate in 2021 ICR Conference
05 Jan 2021 16:05:00 By Nasdaq GlobeNewswire
-
04 Jan 2021 16:05:00 By Nasdaq GlobeNewswire